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The KCL025 human embryonic stem cell line was derived from an embryo donated for research that carried an
autosomal dominant mutation in the NF1 gene encoding neuroﬁbromin (c.3739–3742 ΔTTTG). Mutations in
this gene have been linked to neuroﬁbromatosis type 1, juvenile myelomonocytic leukemia and Watson syn-
drome. The ICM was isolated using laser microsurgery and plated on γ-irradiated human foreskin ﬁbroblasts.
Both the derivation and cell line propagation were performed in an animal product-free environment. Pluripo-
tent state and differentiation potential were conﬁrmed by in vitro assays.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
Resource table
Name of stem cell
line
KCL025
Institution King's College London, London UK
Derivation team
Neli Kadeva, Victoria Wood, Glenda Cornwell,
Stefano Codognotto, Emma Stephenson
Contact person
and email
Dusko Ilic, email: dusko.ilic@kcl.ac.uk
Date
archived/stock
date
Mar 31, 2011
Type of resource Biological reagent: cell line
Sub-type Human pluripotent stem cell line
Origin Human embryo
Key marker
expression
Pluripotent stem cell markers: NANOG, OCT4, TRA-1-60,
TRA-1-81, alkaline phosphatase (AP) activity
Authentication Identity and purity of line conﬁrmed
Link to related
literature
(direct URL links
and full
references)
1) Ilic, D., Stephenson, E., Wood, V., Jacquet, L., Stevenson, D.,
Petrova, A., Kadeva, N., Codognotto, S., Patel, H., Semple, M.,
Cornwell, G., Ogilvie, C., Braude, P., 2012. Derivation and
feeder-free propagation of human embryonic stem cells
under xeno-free conditions. Cytotherapy. 14 (1), 122–128.
doi: 10.3109/14653249.2011.623692
http://www.ncbi.nlm.nih.gov/pubmed/22029654
2) Stephenson, E., Jacquet, L., Miere, C., Wood, V., Kadeva, N.,
Cornwell, G., Codognotto, S., Dajani, Y., Braude, P., Ilic, D.,
(continued)
Name of stem cell
line
KCL025
2012. Derivation and propagation of human embryonic
stem cell lines from frozen embryos in an animal
product-free environment. Nat. Protoc. 7 (7), 1366–1381.
doi: 10.1038/nprot.2012.080
http://www.ncbi.nlm.nih.gov/pubmed/22722371
Information in
public
databases
KCL025 is a National Institutes of Health (NIH) registered hESC
line
NIH Registration Number: 0221
NIH Approval Number: NIHhESC-13-0221
http://grants.nih.gov/stem_cells/registry/current.htm?id=661
Ethics
The hESC line KCL025 is derived under license from the UK
Human Fertilisation and Embryology Authority (research
license numbers: R0075 and R0133) and also has local ethical
approval (UK National Health Service Research Ethics
Committee Reference: 06/Q0702/90).
Informed consent was obtained from all subjects and the
experiments conformed to the principles set out in the WMA
Declaration of Helsinki and the NIH Belmont Report. No
ﬁnancial inducements are offered for donation.
Resource details
Consent signed Oct 28, 2010
Embryo used Mar 03, 2011
UK Stem Cell Bank
Deposit Approval
Dec 01, 2011
Reference: SCSC11-48
Sex Male 46, XY
Grade Research
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⁎ Corresponding author.
E-mail address: dusko.ilic@kcl.ac.uk (D. Ilic).
http://dx.doi.org/10.1016/j.scr.2016.01.009
1873-5061/© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Contents lists available at ScienceDirect
Stem Cell Research
j ourna l homepage: www.e lsev ie r .com/ locate /scr
(continued)
Consent signed Oct 28, 2010
Disease status
(Fig 1)
Autosomal dominant mutation in the NF1 gene
encoding neuroﬁbromin (c.3739–3742 ΔTTTG)
Karyotype (aCGH) ND
DNA ﬁngerprint ND
HLA typing HLA-A: 11,26; -B: 55,57; -C 03,06; DRB1: 04,07
Viability testing Pass
Pluripotent markers
(immunostaining)
(Fig 2)
NANOG, OCT4, TRA-1-60, TRA-1-81, AP activity
Three germ layers
differentiation in vitro
(immunostaining)
(Fig 3)
Endoderm: AFP (α-fetoprotein)
Ectoderm: TUBB3 (tubulin, β3 class III)
Mesoderm: ACTA2 (actin, α2, smooth muscle)
Sibling lines available KCL024
ND, not determined.
We generated KCL025 clinical grade hESC line following protocols,
established previously (Ilic et al., 2012; Stephenson et al., 2012). The
expression of the pluripotency markers was tested after freeze/thaw
cycle. Differentiation potential into three germ layers was veriﬁed
in vitro.
Materials and methods
Consenting process
We distribute Patient Information Sheet (PIS) and consent form to
the in vitro fertilization (IVF) patients if they opted to donate to research
embryos that were stored for 5 or 10 years. They mail signed consent
back to us and that might be months after the PIS and consent were
mailed to them. If in the meantime new versions of PIS/consent are
implemented, we do not send these to the patients or ask them to
re-sign; the whole process is done with the version that was given
them initially. The PIS/consent documents (PGD-V.8) were created on
Jul. 01, 2010. HFEA Code of Practice that was in effect at the time of
document creation: Edition 8–R.2 (http://www.hfea.gov.uk/2999.
html). The donor couple signed the consent on Oct. 28, 2010. HFEA
Code of Practice thatwas in effect at the time of donor signature: Edition
8–R.2. HFEA Code of Practice Edition 8–R.2 was in effect 07 Apr.
2010–Apr. 06, 2011.
Embryo culture and micromanipulation
Embryo culture and laser-assisted dissection of inner cell mass
(ICM) were carried out as previously described in details (Ilic et al.,
2012; Stephenson et al., 2012). The cellular area containing the ICM
was then washed and transferred to plates containing mitotically
inactivated human neonatal foreskin ﬁbroblasts (HFFs).
Cell culture
ICM plated onmitotically inactivated HFF was cultured as described
(Ilic et al., 2012; Stephenson et al., 2012). TE cells were removed
mechanically from outgrowth (Ilic et al., 2007, 2010). hESC colonies
were expanded and cryopreserved at the third passage.
Fig. 1. Genetic pedigree tree. Male donor was carrying an autosomal dominant mutation
c.3739–3742 ΔTTTG in the NF1 gene. The couple undergoing IVF and prenatal genetic
diagnosis had 6 embryos in this particular cycle. Embryos carrying the mutation in the
NF1 gene were donated for research. We derived two hESC lines: KCL024 and KCL025.
Fig. 2. Expression of pluripotency markers. Pluripotency is conﬁrmed by immunostaining (Oct4, Nanog, TRA-1-60, TRA-1-81) and alkaline phosphatase (AP) activity assay. Actin stress
ﬁbers, visualized with rhodamine-phalloidin (red), are present in both feeders and hES cell colonies, whereas AP activity (green) is detected only in hES cells. Scale bar, 50 μm.
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Viability test
Straws with the earliest frozen passage (p.2–3) are thawed and new
colonies are counted three days later. These colonies are then expanded
up to passage 8, atwhich point cells were part frozen and part subjected
to standard battery of tests (pluripotency markers, in vitro and in vivo
differentiation capability, genetics, sterility, mycoplasma).
Pluripotency markers
Pluripotencywas assessed using two different techniques: enzymat-
ic activity assay [alkaline phosphatase (AP) assay] and immunostaining
as described (Ilic et al., 2012; Stephenson et al., 2012; Petrova et al.,
2014).
Differentiation
Spontaneous differentiation into three germ layers was assessed
in vitro as described (Ilic et al., 2012; Stephenson et al., 2012; Petrova
et al., 2014).
HLA typing
HLA-A, -B and -DRB1 typing was performed with a PCR sequence-
speciﬁc oligonucleotide probe (SSOP; Luminex, Austin, TX, USA)
hybridization protocol at the certiﬁed Clinical Transplantation Laborato-
ry, Guy's and St Thomas' NHS Foundation Trust and Serco Plc. (GSTS) Pa-
thology (Guy's Hospital, London, UK) as described (Jacquet et al., 2013).
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Fig. 3. Differentiation of three germ layers in vitro is conﬁrmed by detection of markers: smooth muscle actin (ACTA2, red) for mesoderm, β-III tubulin (TUBB3, red) for ectoderm andα-
fetoprotein (AFP, red) for endoderm. Nuclei are visualized with Hoechst 33342 (blue). Scale bar, 100 μm.
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